Jemincare
Jemincare
Explore linked clinical trials.19 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Study of JY1001 Injection | Pain After Surgery | Not yet recruiting | Phase 1 | 2026-09-30 | NCT07848945 | |
| A Study of JMKX003142 Tablet to Treat Renal Edema | Edema, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Phase 3 | 2026-09-30 | NCT07841093 | |
| Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Recruiting | Phase 3 | 2026-08-03 | NCT07402213 | |
| Drug-Drug Interactions of JMKX003142 in Healthy Participants | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Not yet recruiting | Phase 1 | 2026-05-04 | NCT07565441 | |
| Trial of JYB1904 Injection in Adolescent Participants | Allergic Diseases | Not yet recruiting | Phase 1 | 2026-04-07 | NCT07513857 | |
| A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Not yet recruiting | Phase 1 | 2026-03-13 | NCT07470177 | |
| Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Not yet recruiting | Phase 1 | 2026-03-10 | NCT07463053 | |
| Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, rhinitis | Not yet recruiting | Phase 2 | 2026-03-09 | NCT07459452 | |
| A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2025-12-01 | NCT07208136 | |
| Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 3 | 2025-11-21 | NCT07242274 | |
| Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Not yet recruiting | Phase 1 | 2025-09-18 | NCT07181265 | |
| Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Recruiting | Phase 2 | 2025-07-03 | NCT06800651 | |
| A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2025-07-01 | NCT06946927 | |
| A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion | Neoplasms by Site, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, myeloproliferative disorder, chronic, with eosinophilia, neoplasm, pleural disorder, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2025-04-04 | NCT06740019 | |
| Study of JMKX003948 Ophthalmic Suspension in Healthy Participants | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Not yet recruiting | Phase 1 | 2025-02-18 | NCT06832657 | |
| Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia | Nutritional and Metabolic Diseases, hyperphosphatemia, metabolic disease, phosphorus metabolism disease | Recruiting | Phase 2 | 2025-02-03 | NCT06664125 | |
| Trial of JYB1904 in Chronic Spontaneous Urticaria. | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Recruiting | Phase 2 | 2024-11-29 | NCT06509334 | |
| Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Not yet recruiting | Phase 1 | 2024-10-26 | NCT06658964 | |
| A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma | Renal Cell Carcinoma Metastatic | Recruiting | Phase 1 | 2024-07-09 | NCT06321250 |